SCHEMBL1697207

SCHEMBL1697207

Cc1ccc2c(c1)-c1cc([N+](=O)[O-])ccc1C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
TLR9 Q9NR96 2/20 0.53
MEN1 O00255 1/20 0.53
LMNA P02545 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 1/20 0.53
ACHE P22303 2/20 0.52
HSD17B10 Q99714 1/20 0.52
TSHR P16473 5/20 0.50
PGR P06401 1/20 0.49
ALDH1A1 P00352 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
TDP2 O95551 1/20 0.46
PTPRC P08575 1/20 0.46
S100A4 P26447 1/20 0.46
PNMT P11086 3/20 0.45
ADRA2A P08913 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
METAP1 P53582 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8088143 0.93 TLR9 (0.62) MAPTTLR9MEN1LMNARAB9A
SCHEMBL18849687 0.86 TLR9 (0.66) MAPTTLR9MEN1LMNARAB9A
SCHEMBL7618863 0.81 MAPT (0.58) MAPTTLR9MEN1LMNARAB9A
SCHEMBL546147 0.79 METAP1 (0.57) MAPTMEN1RAB9AKMT2AACHE
SCHEMBL29633503 0.79 METAP1 (0.57) MAPTMEN1RAB9AKMT2AACHE
SCHEMBL987760 0.77 TLR9 (0.79) MAPTTLR9MEN1LMNARAB9A
SCHEMBL30049268 0.77 TLR9 (0.79) MAPTTLR9MEN1LMNARAB9A
SCHEMBL14852072 0.77 PTPRC (0.79) MAPTMEN1KMT2AACHEHSD17B10
SCHEMBL14027231 0.77 ALDH1A1 (0.55) MAPTMEN1LMNAKMT2AACHE
SCHEMBL12238607 0.77 PTPRC (0.72) MAPTMEN1KMT2AACHEHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9671693-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-06 US disclosed
US-9671693-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-06 US disclosed
US-8951709-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-02-10 US disclosed
US-8530138-B2 Salt and photoresist composition comprising the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-09-10 US disclosed
US-8431326-B2 Salt and photoresist composition comprising the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-30 US disclosed
US-8426106-B2 Photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-23 US disclosed
US-8426106-B2 Photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-23 US disclosed
US-20120156620-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-06-21 US disclosed
US-20120100482-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-26 US disclosed
US-20120088190-A1 SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-12 US disclosed
US-20120052440-A1 SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 US disclosed
US-20110091808-A1 PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-21 US disclosed
US-20110091808-A1 PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-21 US disclosed
US-20110091807-A1 PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120052440-A1 SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME C1S, C1R, CLIC1 MAPT 1288/4885TLR9 1372/4885MEN1 1232/4885
US-20110091808-A1 PHOTORESIST COMPOSITION ASIC1, ASIC3, SUN2 MAPT 54/4885TLR9 2200/4885MEN1 3355/4885
US-20110091807-A1 PHOTORESIST COMPOSITION H1-0, H1-2, H1-3 MAPT 923/4885TLR9 2044/4885MEN1 2450/4885
US-20120088190-A1 SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME AFF1, FGFR1, FRG1 MAPT 3136/4885TLR9 1715/4885MEN1 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.